Evelo Biosciences Investor Relations Material

Evelo Biosciences, Inc. (EVLO) is a clinical-stage biotechnology company engaged in the discovery and development of novel oral medicines. These medicines are designed to act on immune cells within the small intestine, with the aim of achieving systemic effects. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the OTC markets.